Nantahala Capital Management, LLC — 13F Holdings & Portfolio

CIK 1472322 · latest 13F-HR filed 2026-08-19

Nantahala Capital Management, LLC manages $3.01B in 13F-reported U.S. long-equity assets across 155 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are IWM (19.93%), PTON (3.22%), HLF (2.88%). Quarter over quarter (versus its 2026-06-30 filing) the fund opened 3 new positions, exited 0, added to 0, and trimmed 0.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Filer Information
Address
130 MAIN ST.
2ND FLOOR
NEW CANAAN, CT 06840
Phone
(203) 404-1172
Filing Manager
Nantahala Capital Management, LLC
NEW CANAAN, CT
Signatory
Taki Vasilakis
Chief Compliance Officer
Loading holdings…
AUM

$3.01B

Long-equity book

Holdings

155

Distinct positions

Period

2026-06-30

Filed 2026-08-19

Q/Q Activity

+3 / −0 / ↑0 / ↓0

vs 2026-06-30

Firm Profile & Key People
Name Title / Status Ownership Type

Top Adds (vs prior quarter)

  • No increased positions.
Show all 0 →

Top Trims

  • No decreased positions.
Show all 0 →

New Positions

  • SERVICE PROPERTIES TRUST$9.0M
  • CURIS INC$1.0M
  • SENTI BIOSCIENCES HOLDINGS$976.8K
Show all 3 →

Exited Positions

  • No exits this quarter.
Show all 0 →
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 ISHARES TR Put IWM 464287655 $600.9M 19.93% 2,000,000 SH
2 PELOTON INTERACTIVE INC Call PTON 70614W100 $97.2M 3.22% 16,438,900 SH
3 HERBALIFE LTD Call HLF G4412G101 $86.8M 2.88% 6,600,000 SH
4 VIATRIS INC Call VTRS 92556V106 $79.4M 2.63% 5,000,000 SH
5 BANCORP INC DEL TBBK 05969A105 $77.7M 2.58% 1,239,887 SH
6 EDWARDS LIFESCIENCES CORP Put EW 28176E108 $72.4M 2.40% 800,000 SH
7 SPDR SERIES TRUST Put XBI 78464A870 $63.3M 2.10% 400,000 SH
8 BIOVENTUS INC BVS 09075A108 $56.6M 1.88% 6,000,279 SH
9 HILTON GRAND VACATIONS INC Call HGV 43283X105 $56.3M 1.87% 1,075,000 SH
10 HILTON GRAND VACATIONS INC HGV 43283X105 $54.1M 1.79% 1,033,170 SH
11 SAVARA INC SVRA 805111101 $43.0M 1.43% 6,976,810 SH
12 ETON PHARMACEUTICALS INC ETON 29772L108 $42.6M 1.41% 1,175,951 SH
13 AMNEAL PHARMACEUTICALS INC AMRX 03168L105 $39.3M 1.30% 2,268,751 SH
14 EVOLUS INC EOLS 30052C107 $38.9M 1.29% 5,602,021 SH
15 ETF SER SOLUTIONS Put QTUM 26922A420 $36.9M 1.22% 223,000 SH
16 UNIQURE NV Call QURE N90064101 $36.8M 1.22% 800,000 SH
17 AVALO THERAPEUTICS INC AVTX 05338F306 $34.4M 1.14% 1,862,250 SH
18 LB PHARMACEUTICALS INC LBRX 50180M108 $34.2M 1.13% 1,052,894 SH
19 NEUROCRINE BIOSCIENCES INC Call NBIX 64125C109 $33.7M 1.12% 200,000 SH
20 PRAXIS PRECISION MEDICINES I Put PRAX 74006W207 $33.5M 1.11% 100,000 SH
21 ANTERIS TECHNOLOGIES GLOBAL AVR 03675P102 $33.3M 1.11% 3,383,335 SH
22 ABEONA THERAPEUTICS INC ABEO 00289Y206 $31.7M 1.05% 5,136,490 SH
23 KRYSTAL BIOTECH INC Put KRYS 501147102 $31.6M 1.05% 85,000 SH
24 PELOTON INTERACTIVE INC PTON 70614W100 $30.2M 1.00% 5,108,995 SH
25 ESTABLISHMENT LABS HLDGS INC ESTA G31249108 $28.8M 0.96% 335,830 SH
26 XTANT MED HLDGS INC XTNT 98420P308 $28.8M 0.96% 68,394,000 SH
27 JACK IN THE BOX INC JACK 466367109 $27.3M 0.91% 1,728,659 SH
28 GOGO INC GOGO 38046C109 $27.0M 0.89% 8,697,731 SH
29 IMAX CORP IMAX 45245E109 $26.2M 0.87% 658,009 SH
30 ZEVRA THERAPEUTICS INC ZVRA 488445206 $25.8M 0.85% 1,797,476 SH
31 REGENERON PHARMACEUTICALS Call REGN 75886F107 $24.9M 0.83% 40,000 SH
32 TITAN MACHY INC TITN 88830R101 $23.9M 0.79% 1,133,088 SH
33 RMR GROUP INC RMR 74967R106 $23.6M 0.78% 1,147,902 SH
34 FOSSIL GROUP INC FOSL 34988V106 $22.8M 0.76% 5,505,128 SH
35 FOX FACTORY HLDG CORP FOXF 35138V102 $22.2M 0.74% 1,310,695 SH
36 MINERALYS THERAPEUTICS INC MLYS 603170101 $22.1M 0.73% 820,481 SH
37 RIDENOW GROUP INC RDNW 781386305 $21.8M 0.72% 3,272,845 SH
38 SNAP INC Call SNAP 83304A106 $21.3M 0.71% 4,800,000 SH
39 UNIQURE NV QURE N90064101 $21.0M 0.70% 455,660 SH
40 AURA BIOSCIENCES INC AURA 05153U107 $21.0M 0.69% 2,951,030 SH
41 AGOMAB THERAPEUTICS NV AGMB 00860C102 $20.4M 0.68% 1,568,188 SH
42 FULCRUM THERAPEUTICS INC FULC 359616109 $20.0M 0.66% 5,475,040 SH
43 BENITEC BIOPHARMA INC BNTC 08205P209 $19.9M 0.66% 1,488,371 SH
44 ADMA BIOLOGICS INC ADMA 000899104 $19.8M 0.66% 2,359,993 SH
45 CAMPING WORLD HLDGS INC CWH 13462K109 $19.5M 0.65% 2,551,055 SH
46 BIOCRYST PHARMACEUTICALS INC BCRX 09058V103 $19.0M 0.63% 1,901,160 SH
47 MIMEDX GROUP INC MDXG 602496101 $18.4M 0.61% 4,767,552 SH
48 ABIVAX SA ABVX 00370M103 $17.8M 0.59% 133,759 SH
49 USANA HEALTH SCIENCES INC USNA 90328M107 $17.3M 0.57% 810,074 SH
50 MONTE ROSA THERAPEUTICS INC GLUE 61225M102 $15.8M 0.52% 651,993 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-19 $3.01B 155 0001104659-26-098416
2026-06-30 2026-08-14 $3.00B 152 0001104659-26-097253
2026-03-31 2026-05-15 $2.72B 152 0001104659-26-062659
2025-12-31 2026-02-13 $3.02B 153 0001104659-26-015271
2025-09-30 2025-11-14 $2.88B 153 0001104659-25-112624